(Q34434692)

2 August 2017

1 reference

title

Cerebrovascular dysfunction after subarachnoid haemorrhage: novel mechanisms and directions for therapy (English)

1 reference

2 August 2017

Sobey CG

1

1 reference

PubMed ID

11703398

2 August 2017

language of work or name

1 reference

1 November 2001

1 reference

Clinical and Experimental Pharmacology and Physiology

2 August 2017

1 reference

2 August 2017

28

1 reference

2 August 2017

11

1 reference

2 August 2017

926-929

1 reference

The pathophysiology of cerebral vasospasm

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Mechanisms of cerebral vasospasm in subarachnoid haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Potassium channel function in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Altered membrane properties of cerebral vascular smooth muscle following subarachnoid hemorrhage: an electrophysiological study. I. Changes in resting membrane potential (Em) and effect on the electrogenic pump potential contribution to Em.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Hemolysate-induced contraction in smooth muscle cells of the guinea pig basilar artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Effect of subarachnoid hemorrhage on cerebral vasodilatation in response to activation of ATP-sensitive K+ channels in chronically hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Mechanisms of vasodilation of cerebral vessels induced by the potassium channel opener nicorandil in canine in vivo experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Inhibitory effect of 4-aminopyridine on responses of the basilar artery to nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Role of extracellular Ca2+ in subarachnoid hemorrhage-induced spasm of the rabbit basilar artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Evidence for expression and function of phosphodiesterase type 5 (PDE-V) in rat resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Responses of human basilar and other isolated arteries to novel nitric oxide donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Treatment of experiment delayed cerebral arterial spasm with a beta2-adrenergic stimulator and a phosphodiesterase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

Sildenafil: a review of its use in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03550.X

10.1046/J.1440-1681.2001.03550.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11703398